Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2858 results

Sort By:

Dantrolene in Statin-induced Myopathy

Study ID: NCT06966843
Start Date: 2027-10
End Date: 2030-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

23

Intervention / Treatment

The Dantrols

Placebo

Sponsor

Lots of University

Source: clinicaltrials.gov

Share:
Add to list

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Study ID: NCT07398404
Start Date: 2026-07-01
End Date: 2031-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

64

Intervention / Treatment

Naltrexone hydrochloride

Bupropion Hydrochloride Extended-release

Cognitive-Behavioral Therapy

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults

Study ID: NCT04806347
Start Date: 2026-04
End Date: 2030-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft

CliniMACS® System

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Anterior Cruciate Ligament (ACL) Reconstruction With Bone Tendon Bone Autograft With Versus Without Internal Bracing

Study ID: NCT05532189
Start Date: 2026-09
End Date: 2032-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

ACL reconstruction with BTB autograft with internal brace augmentation (suture tape)

ACL reconstruction with BTB autograft without internal brace augmentation (suture tape)

Standardized Rehabilitation Protocol

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy

Study ID: NCT07406815
Start Date: 2026-06-01
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

144

Intervention / Treatment

ICG (Indocyanine Green)

Sponsor

Fujian Medical University Union Hospital

Source: clinicaltrials.gov

Share:
Add to list

Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers

Study ID: NCT04940533
Start Date: 2027-01-01
End Date: 2028-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Terazosin And Metabolic Engagement in Parkinson's Disease

Study ID: NCT07288450
Start Date: 2026-09-01
End Date: 2031-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Terazosin Hydrochloride

Placebo

Sponsor

Nandakumar Narayanan

Source: clinicaltrials.gov

Share:
Add to list

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia

Study ID: NCT07263685
Start Date: 2026-03-15
End Date: 2026-05-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

No intervention

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Opioid Dispenser for Microdiscectomy/Laminectomy

Study ID: NCT06358040
Start Date: 2026-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Opioid-Dispensing Device

App

Standard Opioid Pill Bottle

Sponsor

Hospital for Special Surgery, New York

Source: clinicaltrials.gov

Share:
Add to list

Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.

Study ID: NCT07398508
Start Date: 2026-06-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

6

Intervention / Treatment

Droxidopa Oral Product

Placebo Control

Sponsor

Stephen G. Kaler

Source: clinicaltrials.gov

Share:
Add to list